维普中文期刊产品整合服务
14篇 您的检索式:作者名="Bhuva N"
    题名 作者 年代 出处 被引量
1Use of raltitrexed as an alterna- tive to 5-fluorouracil and capecitabine in cancer patients with cardi- ac history显示文摘Kelly C Bhuva N Harrison M 2013EurJ Cancer2013,49,10:1
2Use of rahitrexed as an al- ternative to 5-fluorouracil and capeeitabine in cancer patients with cardiac history显示文摘Kelly C Bhuva N Harrison M 2013Eur J Cancer2013,49,10:1
3Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history显示文摘Kelly C Bhuva N Harrison M 2013Eur J Cancer2013,49,10:1
4Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history显示文摘Kelly C Bhuva N Harrison M 2013Eur J Cancer2013,49,10:1
5Simulation of SEU transients in CMOS ICs 显示文摘Kaul N Bhuva B L Kerns S E 1991IEEE Trans on Nuclear Science1991,38,6:1
6Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history 显示文摘KELLY C BHUVA N HARRISON M 2013Eur J Cancer2013,49,10:1
7Simulation of SEU transients in CMOS ICs显示文摘Kaul N Bhuva B L Kerns S E 1991IEEE Transactions of Nuclear Science1991,38,6:1
8Use of raltit- rexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history显示文摘KELLY C BHUVA N HARRISON M 2013European Journal of Cancer (Oxford England 1990)2013,49,10:1
9Use of raltitrexed as an alter- native to 5 - fluorouracil and capecitabine in cancer patients with cardiac history显示文摘Kelly C Bhuva N Harrison M 2013Eur J Cancer2013,49,10:1
10Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history显示文摘Kelly C Bhuva N Harrison M 2013Eur J Cancer2013,49,10:1
11Use of raltitrexed as an alter- native to 5 flnorouracil and capecitabine in cancer patients with car diachistory显示文摘Kelly C Bhuva N Harrison M 2013Eur J Cancer2013,49,10:1
12Use ofraltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history显示文摘Kelly C Bhuva N Harrison M 2013Eur J Cancer2013,49,10:1
13Use of raltitrexed as an alterna- tive to 5-fluorouracil and capecitabine in cancer patients with car- diac history显示文摘Kelly C Bhuva N Harrison M 2013Eur J Cancer2013,49,10:1
14经血压校正的动脉僵硬度指标的预测价值:脉搏波传导速度、心踝血管指数与血压校正的心踝血管指数的比较显示文摘Am J Hypertens,2022,35(3):272-280.脉搏波传导速度(pulse wave velocity,PWV)测值受血压影响,促进了血压校正指标心踝血管指数(cardio-ankle vascular index,CAVI)和CAVI0(通过理论/数学模型对CAVI进行额外的血压校正得到)的发展。本研究旨在评估心踝动脉PWV(heart-to-ankle PWV,haPWV)、CAVI和CAVI0在美国人群风险预测中的价值。Spronck B Obeid MJ Paravathaneni M Gadela NV Singh G Magro CA Kulkarni V Kondaveety S Gade KC Bhuva R Kulick-Soper CM Sanchez N Akers S Chirinos JA 刘青 郑武洪 2023中华高血压杂志2023,31,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费